Clinical Trial Update: Coronary Bifurcation Lesions Treated With Biguard Stent System [NA]

View source ↗

Summary

Clinical trial investigating the Biguard Stent System for coronary bifurcation lesions has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Biguard Stent System

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Coronary Artery Disease | NA | Status: WITHDRAWN